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ABSTRACT SNCI, a gene from the yeast Saccharomyces
cerevisiae, encodes a homolog of vertebrate synaptic vesicle-
associated membrane proteins (VAMPs) or synaptobrevins.
SNCI was isolated by its ability to suppress the loss of CAP
function in S. cerevisiae strains possessing an activated allele of
RAS2. CAP is a component of the RAS-responsive S. cerevisiae
adenylyl cyclase complex. The N-terminal domain of CAP is
required for full cellular responsiveness to activated RAS
proteins. The C-terminal domain of CAP is required for
normal cellular morphology and responsiveness to nutrient
extremes. Multicopy plasmids expressing SNCI suppress only
the loss of the C-terminal functions of CAP and only in the
presence of activated RAS2.
The yeast Saccharomyces cerevisiae contains two RAS
genes that encode proteins highly homologous to mammalian
RAS oncogene products (1, 2). These RAS proteins are
required to activate S. cerevisiae adenylyl cyclase (3, 4) but
may have other functions as well (5). The functions of RAS
in higher organisms are not known. When expressed in S.
cerevisiae, mammalian RAS proteins are capable of both
activating adenylyl cyclase and suppressing the lethality
associated with the loss ofendogenous RAS function (3, 5, 6).
Thus, some functions of RAS may have been conserved
during the course ofevolution. To explore this we have begun
to characterize the S. cerevisiae adenylyl cyclase complex.
We previously identified a protein called CAP that copu-
rifles with a RAS-responsive adenylyl cyclase complex (7).
The gene for CAP encodes a 526-residue protein that is
required for full cellular responsiveness to activated RAS and
for normal cellular morphology and responsiveness to nutri-
ent extremes (8, 9). Deletion analysis has shown that CAP is
bifunctional (10). Expression of a domain consisting of the
N-terminal 168 amino acids is sufficient for full cellular
responsiveness to activated RAS, while expression of the
C-terminal 160 amino acids is sufficient for normal cellular
responses to nutrient extremes (10). At present, it is unclear
whether RAS or adenylyl cyclase influences CAP function.
To understand the function ofCAP, we have isolated genes
that on multicopy plasmids are capable of suppressing loss of
C-terminal function. One such gene, PFY, encodes profilin,
an actin binding protein (11). Another gene, which we have
named SNC) (suppressor of the null allele of CAP), is
described here. It encodes a protein homologous to low
molecular weight proteins known as VAMPs (synaptic ves-
icle-associated membrane proteins) (12, 13) or synaptobre-
vins (14-16) that are associated with synaptic vesicles and are
found in a wide variety of organisms.§
MATERIALS AND METHODS
Microbial Culture. Yeast strains were grown in rich medium
(YPD; yeast extract/Bactopeptone/dextrose), synthetic com-
plete minimal medium (SC), or SC drop-out minimal medium
lacking an essential amino acid or nucleotide base. Drop-out
minimal medium was used to maintain selection of plasmids.
Yeast extract, Bactopeptone, and yeast nitrogen base lacking
ammonium sulfate and amino acids (YNB) were purchased
from Difco. YPD was prepared according to Sherman et al.
(17). SC minimal complete and drop-out media were prepared
as described by Sherman et al. (17) and consisted of0.7%YNB
supplemented with the appropriate auxotrophic requirements
and 2% glucose. Yeast medium lacking in amino acids and a
nitrogen source (YNB-N) was prepared according to Toda et
al. (4). Standard methods were used to introduce plasmids into
the various yeast strains (17). Escherichia coli strains HB101
and DH5a were used for plasmid transformations and plasmid
DNA preparations.
Yeast Strains. cap yeast strains SKN32 (Mata leu2 ura3
trp) ade8 can) cap::HIS3) and SKN37 (Mata leu2 ura3 trp)
ade8 can) RAS2V1l19 cap::HIS3) have been described (9).
This cap:.HIS3 allele lacks amino acids 78-451 of the coding
region of CAP and is a null allele. cap strain SK013 (Mata
leu2 ura3 trp) ade8 can) cap::HIS3) has also been described
(9). cap strain SKN50 (Mata leu2 trp) ade8 can) iral::HIS3
cap:: URA3) was created by transforming the iral strain IR-1
(18) with the EcoRI fragment of the CAP disruption plasmid
pUSMN2 as described (9). cap strains SKN55 and SKN56
(Mata ade8 can) bcy)::LEU2 tpk2::HIS3 tpk3::TRP)
cap:: URA3) were created by transforming the bcy) tpk2 tpk3
strain S13-58A (19) with the EcoRI fragment of pUSMN2
CAP disruption plasmid. cap strains SKN58 and SKN59
(Mata ade8 trp) can) pdel::LEU2 pde2::URA3 cap::HIS3)
were created by transforming the pdel pde2 strain DJ23-3C
(20) with the EcoRI fragment of the CAP disruption plasmid
pHSPN5 as described (9). HIS3+ transformants were isolated
and the disruption of CAP was verified by phenotypic and
Southern blot analysis. The snc) strain JG4 (Mata leu2 trp)
ade8 his3 can) snc):: URA3) was constructed by transform-
ing the haploid SP1 yeast strain (Mata leu2 ura3 trp) ade8
his3 can)) (4) with the Sal I/Sac I fragment of the SNCI
disruption plasmid pORF3U (see below). Integration of this
construct at the SNC) locus results in an insertion in SNC).
The snc) strain JG5 (Mata leu2 trp) ade8 his3 can)
snc)A::URA3) was created by transforming the haploid SP1
yeast strain with the Sal I/Sac I fragment of the SNC)
disruption plasmid pNCSU (see below). Integration of this
Abbreviations: VAMP, synaptic vesicle-associated membrane pro-
tein; ORF, open reading frame.
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construct at the SNCJ locus results in deletion of the SNCI
gene. Diploid yeast, formed by mating DC124 (Mata leu2
ura3 trpl ade8 his4) (19) and SP1, were also transformed with
the Sal I/Sac I fragment of pORF3U. Ura' transformants
were sporulated and subjected to tetrad analysis (17). Dis-
tribution of the URA3 marker in haploid strains derived from
tetrad analysis was found to be 2:2. In all the cases described
above, genotypes were verified by Southern blot analysis.
DNA Manipulations. DNA restriction endonucleases, Taq
polymerase, and T4 DNA ligase were used as recommended
by the suppliers (New England BioLabs and Cetus). Molec-
ular cloning, Southern blotting, and colony hybridization
techniques were performed as described by Maniatis et al.
(21). DNA sequencing was performed by the dideoxynucle-
otide chain-termination method (22). The polymerase chain
reaction (PCR) (23) and subcloning of PCR products were
carried out as described (10). Oligonucleotides used to am-
plify SNCJ included a forward oligonucleotide bearing a Sal
I site (5'-AACGTATTCGTCGACCATGTCGTC-3') and a
reverse oligonucleotide bearing a Sac I site (5'-CTA-
CATATGGGAGCTCCCTAT-3'). Total RNA was isolated
from wild-type yeast (SP1) according to Sherman et al. (17).
Isolation of poly(A)+ RNA was accomplished with a kit from
Stratagene. First-strand cDNA synthesis from yeast
poly(A)+ RNA, which was used as a template for PCR, was
accomplished with a cDNA synthesis kit from Bethesda
Research Laboratories.
Genomic DNA from a YPD' revertant of the SK013 cap
mutant strain (9) was isolated according to Sherman et al.
(17). The DNA was partially digested with the Sau3A re-
striction endonuclease and size-fractionated by gel electro-
phoresis. A library was constructed in the yeast expression
plasmid YEp13M4 (20) from size-selected DNA cloned into
the BamHI site of the vector.
Phenotypic Assays and Selections. cap strain SKN37 was
transformed with the library and grown for 48 hr on selective
medium before replica plating onto YPD plates to assay for
growth on rich medium. Of2000 Leu+ transformants, 30 were
YPD+, only one of which was found to grow on rich medium
in a plasmid-dependent manner. Plasmids were isolated from
yeast according to standard methods (17). Candidate plas-
mids were then retransformed back into the cap SKN37
strain and were examined for their ability to confer growth on
YPD. Assays for growth on rich medium, temperature-
sensitive growth at 37°C, and sensitivity to nitrogen starva-
tion or heat shock (55°C) were performed as described (10).
Plasmids. Plasmids used in this study included the following
vectors: YEp13M4, yeast expression plasmid bearing the
LEU2 selectable marker (20); pAD4A&, a similar plasmid bear-
ing both the LEU2 selectable marker and the ADHI promoter
(18); and pUV2, pTV3, and pAV3, YEp-based plasmids
bearing the URA3, TRPI, or ADE8 selectable markers, re-
spectively. Previously described plasmids included the fol-
lowing: pADH-CAP, which expresses full-length CAP under
the control of the ADHI promoter (9); pADH-CAPA&4, which
expresses 237 amino acids of the C terminus of CAP (10);
pADH-CAPA15, which expresses 283 amino acids of the N
terminus of CAP (10); and YEpIRA2, which expresses IRA2
(R.-M. Ballester and M.W., unpublished results).
Other plasmids included the following: YEpSNC1, a
YEp13M4 plasmid bearing a 3.4-kilobase (kb) Sau3A partial
digestion fragment of genomic SNC1; YEpTSNC1, a pTV3
plasmid bearing this gene as a Sal I/Sac I fragment; pUC-
SNC, a pUC118 plasmid bearing this fragment; pADH-SNC1
and pADH-cSNC1, which contain a 550-base-pair (bp) frag-
ment ofgenomic SNC1 or a 370-bp fragment ofSNCI cDNA,
cloned into the Sal I and Sac I sites of pAD4A, respectively;
pADH-ASNC1, which bears a 2.3-kb BamHI fragment, con-
taining the ADHI promoter and the SNCJ sequence from
pADH-SNC1, cloned into the BamHI site of pAV3; and
pADH-ACAPA4, which bears a 3.0-kb BamHI fragment,
containing the ADHI promoter and the CAPA4 allele (10)
from pADH-CAPA4, cloned into the BamHI site of pAV3.
The modified pAV3 plasmids were used in the transformation
of cap strains SKN55-56 and SKN58-59.
Two plasmids derived from pUCSNC were used for dis-
ruptions of SNCI: pORF3U, which has the URA3 selectable
marker cloned into the Sty I site (base pair 325) ofSNC1; and
pNCSU, which has URA3 cloned into the Spe I sites, which
flank SNCJ (base pairs -237 and +646, respectively). For
pNCSU, pUCSNC was digested with Spe I, which removes
the entire SNCJ coding region, and the URA3 gene was
cloned into this site. Both disruption constructs were verified
by restriction analysis.
RESULTS
A Yeast Gene That Suppresses Loss of the C-Terminal
Functions of CAP. We have screened a yeast genomic library
for multicopy suppressors of the cap null phenotype of the
SKN37 strain. This strain is unable to grow on the standard
amino acid-rich medium YPD. Expression of the C-terminal
domain ofCAP is fully able to complement this defect (10). Of
2000 transformants only one was capable ofgrowth on YPD in
a plasmid-dependent manner. This transformant contained
YEpSNC1, a plasmid that was found to be as potent a
suppressor of rich medium growth defects in SKN37 cells as
plasmids expressing either full-length CAP or the C-terminal
domain of CAP (Fig. 1). SKN37 cells display other defects
associated with loss of the C-terminal function of CAP,
including large cell size, temperature-sensitive growth, and
inability to withstand nitrogen starvation (9). YEpSNC1 sup-
pressed the abnormal cell size (Fig. 2) and the other growth
defects as well as did plasmids expressing the C-terminal
domain of CAP (data not shown). In contrast, YEpSNC1 did
not suppress loss of the N-terminal functions of CAP, the loss
of full RAS responsiveness. Wild-type yeast expressing the
activated RAS2Va`L9 allele are sensitive to heat shock (24).
SKN37 cells, which contain the activated RAS allele, are
resistant to heat shock because of the absence of the N-ter-
minal domain of CAP (10). SKN37 cells containing the YEp-
SNC1 plasmid remain resistant to heat shock (data not shown).
Strain
SPI (CAPW t)
SKN 37 (Scg RAS2VaI119)
SKN37
SKN 37
SKN 37
SKNS7
Plasmid
YEp 13M4
YEp13M4
pADH-CAPA4
pADH-CAPA15
pADH- CAP
YEpSNC
SC
300C
__-.
YPD
3C0c
FIG. 1. Effect of SNCI on the growth of cap
strains on rich medium. cap yeast strain SKN37
was transformed with yeast episomal plasmids ex-
pressing the C-terminal domain of CAP (pADH-
CAPA4), the N-terminal domain of CAP (pADH-
CAPA15), full-length CAP (pADH-CAP), or SNC1(YEpSNC). Both CAP' (SP1) and cap yeast were
transformed with an empty vector (YEp13M4) as
control. Patches of transformed yeast were grown
for 3 days on synthetic minimal medium (SC) before
replica plating to rich growth medium (YPD).
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FIG. 2. Effect of SNCI on the
morphology of cap yeast. cap yeast
strain SKN37 (RAS2VAl9 cap:.HIS3)
was transformed with either a plasmid
expressing SNC1 (pADH-SNC1) or
YEp13M4 as a control. CAPWt
RAS2Va'l9 yeast were also trans-
formed with YEp13M4 as a control.
Transformed yeast strains were
grown in liquid synthetic medium for
2 days before visual inspection.
(x 1050.)
Sequence of SNC1. The YEpSNC1 plasmid contained an
insert of 3.4 kb. Deletion analysis of the plasmid localized the
full suppressor activity of YEpSNC1 to a 1-kb fragment.
DNA sequencing of this fragment revealed two small open
reading frames (ORFs) (Fig. 3). A search for similar DNA
sequences revealed a strong homology between these ORFs,
when taken together as a single ORF, and members ofa class
of small, highly conserved proteins [VAMPs (12, 13) or
synaptobrevins (14-16)]. These proteins have been identified
in a wide variety of organisms (from fish to humans). Their
function is unknown, but they are suspected to play a role in
vesicle fusion and neurotransmitter release. Two classes of
these proteins have been identified-the type 1 and type 2
VAMP/synaptobrevins, which differ slightly in their N-ter-
minal domains.
Alignment between the translated sequence of the ORFs
and those of the VAMP/synaptobrevin genes suggested that,
together, these ORFs constitute the entire coding region of a
yeast homolog. Several lines of evidence confirm this. First,
SNCI contains sequences that match the consensus sequences
for splice donor and acceptor sites in S. cerevisiae: the 5' splice
motif (GTANGT) and the 3' splice motif (YAG, where Y is
pyrimidine) (25) are found at the candidate intron-exon junc-
tion at base pairs 101-106 and 213-215, respectively. In
addition, the TACTAAC box, a consensus motif present in S.
cerevisiae introns (26), is found at base pairs 146-152. Second,
oligonucleotide-directed amplification of SNC1 from yeast
cDNA by PCR generated a product =100 bp smaller than that
generated when genomic DNA was used as a template (data
not shown). DNA sequencing of the PCR product generated
from yeast cDNA revealed that base pairs 101-215 were
absent. Finally, expression of the PCR-amplified cDNA clone
was able to suppress the CAP-deficient phenotypes ofSKN37
cells (data not shown). These studies demonstrate not only the
existence of an intron but also that we have identified the
correct ORF with suppressor activity.
The ATG codon starting at nucleotide 1 is preceded by
multiple in-frame stop codons. Given this, we conclude that
SNCJ encodes a protein of 117 amino acids and has a
predicted molecular mass of =13 kDa. A 115-bp intron
sequence connects the region encoding the first 33 amino
acids to that encoding the last 84 amino acids.
Homology Between SNC1 and Mammalian VAMPs. The
yeast SNC1 protein is highly homologous to both the type 1
and type 2 mammalian VAMP/synaptobrevins (Fig. 4). The
amino acid sequence of SNC1 shows =40%6 identity and
=50% overall homology to either type of protein. The
VAMP/synaptobrevin protein has been structurally divided
into three distinct regions based on analysis of the secondary
structure and tryptic digestion patterns (12-14, 16). The
N-terminal 80-90 amino acids constitute a highly charged
hydrophilic region that extends into the cytosol (13). The first
20 residues of the N terminus of both the type 1 and type 2
proteins are highly diverged (12, 14). This is the region with
the least homology to yeast SNC1. C-terminal to the cytosolic
domain is a stretch of 20-25 hydrophobic residues that
constitute a transmembrane domain. The last four residues of
the C terminus of the protein are thought to constitute an
intravesicular domain (12-16). The region of strong homology
between SNC1 and the VAMP/synaptobrevins lies down-
stream of residue 20 and extends throughout the hydrophilic
region (residues 21-91) and includes the stretch of -20
hydrophobic amino acids. Computer analysis by the method
of Klein et al. (27) predicts the SNC1 protein to be an integral
membrane protein. The membrane-spanning region consists
of residues 95-111.
Disruption of the SNC1 Locus. The chromosomal SNCJ
locus was disrupted by insertion into, or deletion of, the coding
region of SNCJ by transformation (see Materials and Meth-
ods). Microscopic and phenotypic analysis of confirmed sncl
strains indicated that the disruption of SNC1 has no apparent
phenotype in yeast (data not shown). sncl strains were found
to grow and mate in a normal fashion, were morphologically
normal, and did not show phenotypes that result from loss of
the C-terminal functions ofCAP. Haploid sncl strains derived
from tetrad analysis also had no phenotype. Thus, SNCI does
not, by itself, provide an essential function.
Genetic Interactions Between SNC1 and RAS2. SNCI was
isolated as a suppressor of cap phenotypes in the yeast
SKN37 strain, which contains an activated RAS2Va`l9 allele.
We therefore determined whether SNC1 was also capable of
suppressing cap defects in the cap RAS2' strains SKN32 and
SKN34. In contrast to cells transformed with plasmids ex-
pressing either full-length CAP or the C-terminal domain of
I ATG TCG TCA TOT ACT CCC TTT GAC CCT TAT GCT CTA TCC GAG CAC GAT GAA GAA CGAM S S S T P F D P Y A L S E H D E E
CCC CAG AAT GTA CAG TCT AAG TCA AGG ACTPQ N V QSK S R T
118 CACAGAGTACCATCTAGGAAATTAACATTATaCTA&CTTJ
13 ACGTTCTTCGTGTTTATTTTTAG GAA ATT GAT GATE I D D
255 AAT AAA GTA GCA GAA AGA GST GAA ARA TTA48N K V A E R G E R L
3jj CTA GAG GTC TCA GCC CAA GGC TTT AAG AGG
IL A V A F K R
31g TGO TAC AAG GAT CTA AAA ATG AAG ATG T8T
426 GTT GTA ATC ATC GTC CCC ATT GCT GTT CAC10 V V I I V P I A V H
AC0 GAA CTA CAA OCT
A E L A
ACC GTG GGA ATA ATG
T V G I M
ACG TSC ATT GA GDAT
GGT GCC AAT AGG GTCGA N R V
CTG GOT TTA GTA ATC
L A L V I
TTT AWT CGA TAG
GTAAGTACAGAAAGC
AGA GAT AAC ATA
R D N I
AAA GCC GAT AAC
K A D N
AGA AAA GCC ATG
R K A M
ATC ATA TTG CTT
I I L L
FIG. 3. Sequence of the SNCI
gene and its encoded product. Coor-
dinates for nucleotides and codons
are indicated on the left. The single-
letter amino acid code for the SNC1
protein is given below each 3-bp
codon of the ORFs. The consensus
sequences for intron splicing in S.
cerevisiae are indicated in boldface
type. The stop codon is indicated with
an asterisk.
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RATVAMP1 1 MSAPA--QPPAEGTE--GAAPGGGPPGPPPNTTSNRRLQQTQAQVEEVVDIIRVNVD
11 11 ::: 1:1 1:
Yeast SNC1 1 MSSSTPFDPYALSEHDEER---------PQNVQSKSRTAELQAEIDDTVGIMRDNIN
11: I I 1 1: 11 11:1:I1 1:
RATVAMP2 1 MSATAATVPPA------APAGEGGPPAPPPNLTSNRRLQQTQAQVDEVVDIMRVNVD
53 KVLERDQKLSELDDRADALQAGASVFESSAAKLKRKYWWKNCKMMIMLGAICAIIVVVIVI----YIFT.
11 11 :1: ::I:11 I :::: 1:1 11: 1 : 1::111::
48 KVAERGERLTSIEDKADNLAVSAQGFKRGANRVRKAMWYKDLKMKMCLALVIIILLVVIIVPIAVHFSR.
53
11 11 :I: ::I:11I I :::: 1:1 111: :: 1:1::111
KVLERDQKLSELDDRADALQAGASQFETSAAKLKRKYWWKNLKMMIILGVICAIILIIIIV----Y
I I
TST.
FIG. 4. Comparison between SNC1
and the VAMP/synaptobrevin proteins.
The amino acid sequence of SNC1 was
aligned with the two types of rat VAMP/
synaptobrevin proteins. Vertical bars
designate identities between pairs; dots
represent conservative amino acid sub-
stitutions. Amino acid coordinates are on
the left.
CAP, SKN32 or SKN34 cells transformed with YEpSNC1
remained incapable ofgrowth on rich medium or on synthetic
minimal medium at 37TC and retained their abnormal mor-
phology and sensitivity to nitrogen starvation. These results
suggest that activation of the RAS pathway is required for
SNCI suppressor activity.
To rule out the possibility that undetected genetic differ-
ences between the cap RAS21 strains (SKN32 and SKN34)
and the cap RAS2Va`l9 strain (SKN37) might be affecting the
suppressor activity of SNCJ, we created another cap null
strain, SKN50 (see Materials and Methods). This strain bears
the RAS2Wt allele but also has a disrupted IRA] locus. The
yeast IRA] gene is a functional homolog of the mammalian
GTPase-activating protein (GAP) (18, 28). An iral CAP'
strain shows all the phenotypes associated with persistent
activation of the RAS pathway (3, 24, 28), including heat
shock sensitivity, presumably due to perpetuation ofRAS in
its activated GTP-bound state (29). SKN50 cells, however,
are resistant to heat shock because of loss of the N-terminal
functions of CAP and also show the phenotypes associated
with loss of the C-terminal functions of CAP (data not
shown). The typical iral phenotypes can be restored to
SKN50 cells upon expression of full-length CAP. In contrast
to the results obtained with the SKN32 and SKN34 strains,
but like our results with the SKN37 strain, YEpSNC1 was
able to confer robust growth on rich medium in SKN50 cells
(Fig. SA). In addition, the expression of SNC1 was able to
correct other defects associated with loss of the C-terminal
A
r-; r.
SKN32 (cqp RAS2w)
SKN37 (qcp RAS2Vl 19)
SKN50 (cqq RAS2w irl )
B Strai
SKN50
SKN50
Plasmids
YEpTSNC
YEpTSNC
SKN 50 YEpTSNC
SKN5 vEPTSNC
Plosmid
YEpSNC
YEpSNC
YEpSNC
SC
300c
YEpl3M4
YEp 13M4
YEplRA2
YEpIRA2
SC YPD
eul
YPD SC
300C 37°C
ml=
FIG. 5. Effect of SNCI in cap strains having a disruption of the
IRAI locus. (A) cap strains SKN32 (RAS2'), SKN37 (RAS2VaIS9),
and SKN50 (RAS21 iral) were transformed with a plasmid (YEp-
SNC) expressing SNC1. These strains were also transformed with an
empty vector (YEp13M4) as control (data not shown). After growth
for 3 days on synthetic medium (SC), patches of transformed yeast
were replica plated onto YPD plates to test for growth on rich
medium (YPD). (B) cap strain SKN50 (RAS21 iral) transformed
with a plasmid (YEpTSNC) expressing SNC1 was transformed with
a second plasmid (YEpIRA2) expressing either IRA2 or a control
vector (YEp13M4). Double transformants were grown for 3 days on
synthetic medium (SC) before replica plating onto YPD plates to test
for growth on rich medium (YPD; 30°C) or to prewarmed synthetic
medium to test for temperature-sensitive growth at 37°C (SC; 37°C).
functions of CAP-namely, growth at 37°C (Fig. 5B) and
resistance to nitrogen starvation.
To verify further that the functional activity of SNCI
results from activation of RAS, we coexpressed the yeast
IRA2 gene from a multicopy plasmid containing the LEU2
selectable marker YEpIRA2 and SNC1 from a multicopy
plasmid containing the TRPI selectable marker YEpTSNC1
in SKN50 cells. The IRA2 gene encodes a second GAP-like
protein and is able to functionally complement the loss of
IRA) (30). SKN50 cells transformed with both SNC1 and
IRA2 plasmids were found to grow slowly on YPD and were
unable to grow altogether at 37°C under conditions selective
for the plasmids (Fig. 5B). In contrast, SKN50 cells trans-
formed with the SNCI plasmid and a control plasmid bearing
the LEU2 marker YEp13M4 were capable of strong growth
either on YPD or on synthetic medium at 37°C. Thus, the
overexpression ofIRA2 appears to inhibit the ability ofSNCJ
to suppress the loss of CAP functions in SKN50 cells. This
conclusion was further confirmed by plasmid segregation
analysis (data not shown).
Genetic Interactions Between SNCI and Genes Encoding
Components of the cAMP Pathway. Evidently expression of
SNCI suppresses the phenotype resulting from loss of C-ter-
minal CAP function only in cells that have activated RAS.
One possible explanation for this phenomenon is that acti-
vation ofRAS stimulates the cAMP effector pathway even in
the absence of CAP. We therefore sought to determine
whether the suppressor activity of SNCI was dependent on
stimulation of the cAMP effector pathway. We created four
additional cap mutant strains: two, SKN58 and -59, lacked
the cAMP phosphodiesterases encoded by PDEI and PDE2
(20, 24); and two, SKN55 and -56, lacked the regulatory
subunit of the cAMP-dependent protein kinases encoded by
the BCYI gene (31) and two of the three catalytic subunit
isoforms encoded by the TPK2 and TPK3 genes (32). Wild-
type yeast lacking the PDE genes are unable to hydrolyze
cAMP and are sensitive to heat shock (20). Yeast lacking
BCYJ, but expressing at least one of the TPK genes, are also
heat shock sensitive (31). As expected, disruption of CAP in
these yeast strains had no effect on their sensitivity to heat
shock, because the N-terminal function of CAP is not re-
quired in these strains. Like other cap disruption strains,
SKN55, -56, -58, and -59 were unable to grow on rich medium
and displayed the other defects associated with loss of the
C-terminal functions of CAP. Overexpression of SNCJ was
unable to confer growth on rich medium in these four cap
mutant strains. On the basis of these experiments, it appears
that the functional activity of SNC1 in cap mutant strains is
dependent on the activated state of RAS but not on the level
of cAMP or cAMP-dependent protein kinase activity.
DISCUSSION
The SNCI gene encodes a protein of 117 amino acids that is
highly homologous to members of the VAMP/synaptobrevin
family (12-16), which, because of their subcellular localiza-
tion, are presumed to be involved in targeting and fusion of
synaptic vesicles with the presynaptic membrane (12-16).
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These proteins have a distinct structure, composed of a
C-terminal transmembrane domain and a small cytoplasmic
N-terminal domain. Other proteins of similar overall struc-
ture but with larger cytoplasmic domains are known to
function in the secretory pathway of S. cerevisiae. SNC1 is
very weakly homologous to these other yeast proteins [e.g.,
SLY12/BET1 (33, 34), SLY2 (33), and BOS1 (35)].
A phenotypic assay for the VAMP/synaptobrevins in yeast
would aid in evaluation of their function. Unfortunately,
despite the high degree ofconservation between SNC1 and the
VAMP/synaptobrevins, expression ofeither the type 1 ortype
2 rat VAMP genes does not complement defects seen in cap
cells (data not shown). Suppression of the loss of SNCI
function could in principle provide an assay for VAMP/
synaptobrevin function. Unfortunately, disruption of the
SNCI locus does not cause a discernible phenotype. Recently,
we have found clear evidence for a second VAMP/
synaptobrevin homolog in yeast. Disruption of both homologs
may result in a phenotype that would allow analysis of SNC1
function and also provide a way to use yeast as a model
organism for study of VAMP/synaptobrevin functions.
SNCI is one of two yeast genes that we have described that
were isolated by their ability to complement the cellular
defects associated with loss of the C-terminal functions of
CAP. The first of these, PFY (11), encodes profilin, an
actin/phospholipid binding protein that is presumed to be
involved in cytoskeletal organization (36) but that might also
be involved in inositol phospholipid metabolism (37-39). We
do not understand how profilin suppresses the loss of CAP
function, nor do we understand the mechanism for SNC1
suppression. We have postulated that profilin alters phospho-
lipid metabolism (11), and it is conceivable that SNC1 may
directly or indirectly alter phospholipid content or distribution
within cellular compartments. We are unlikely to resolve this
problem without understanding the normal function of SNC1.
We and others (8, 9) have shown that yeast with a disrupted
CAP locus is at least partly uncoupled from activated RAS
proteins: cells without CAP function do not display the phe-
notypes normally associated with the expression of activated
RAS. Our experiments with SNC1 suggest that cap strains are
in fact at least partly responsive to activated RAS, although
apparently in a manner independent of the RAS-adenylyl
cyclase interaction. SNC1 is capable of suppressing defects
associated with loss of the C-terminal function ofCAP only in
strains with constitutively activated RAS2 protein. SNCI is
unable to confer suppressor activity in cap strains bearing the
RAS21 allele, even when other negative regulators of the
cAMP effector pathway are absent. Thus, the suppressor
activity of SNC1 appears to be independent of the presently
known downstream effectors of RAS in yeast. This result
confirms that RAS proteins in the yeast S. cerevisiae have
functions in addition to regulation of adenylyl cyclase (5).
Moreover, these functions do not depend on CAP.
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